chrisvoncsefalvay/vaers-outcomes huggingface dataset:
suspected vaccination failure; a friend has had shingles since Nov / get the shingles from the shot; This case was reported by a consumer described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In November 2020, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   The reporter considered the vaccination failure and shingles to be possibly related to Shingles vaccine.  Additional details were provided as follows: Reporter was patient's friend. The age at vaccination was not reported. The patient received shingles shot and had shingles. Reporter stated that it was 1 in 10000 that get the shingles,from the shot but the patient was one of that. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.
Alcoholic cirrhosis of liver with ascites. ED visits and multiple hospital admissions within 6 weeks of receiving the COVID vaccine.
Presented to the emergency room because of exertional dyspnea; admitted for COVID-19 infection; tx w/abx, steroids, remdesivir, O2, zinc; weaned to RA for dc to home.
Tinnitus, mild ringing in both ears, stronger in left ear. Left ear also feels slightly "congested". Hearing doesn't seem affected, but ringing is constant. No previous hearing loss or damage.
Raised red area 3 inches by 6 inches on upper arm.  Warm to touch.  Appeared 12 days after injection.
Bell?s palsy. Left eye will not close and left mouth droopy with muscle weakness left side.
No other AE reported.; temperature excursion for GARDASIL 9; This spontaneous report has been received from a healthcare business professional (HBP) referring to a patient of unknown age and gender. Information about medical history, concurrent conditions, concomitant therapies and drug allergies was not provided.  On 11-JAN-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (0.5 ml, lot # 1602284 has been verified to be a valid lot number, expiration date was 26-SEP-2021) via unknown route for prophylaxis. The hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was involved in temperature excursion (product storage error). The vaccine was stored at the temperature of 31.2 degrees Fahrenheit for 30 minutes. There were no previous temperature excursions. The digital data logger was involved. No product to retrieve. No other adverse event (AE) reported.  This is one of several reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1602284; expirationdate: 26-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
This spontaneous report as received from a Nurse refers to unspecified patients of unknown age and gender. On an unknown date the patients might have received VARIVAX (Merck), reconstituted with expired doses of sterile diluent (lot number H006212, expiration 30-JUN-2014). No adverse effects were reported. This is one of three reports from the same source. Additional information has been requested.
Extreme ovary cramping and pain- consistent, debilitating cramping and pain for 8 hours
Fever of 101.6, shivering, nausea, total body muscle aches, tired, headache.
SEVERE CHILLS , FEVER, , BACK PAIN,  UNABLE TO WALK FOR FEW MINUTES
Approximately 8 hours after administration of vaccine, patient awoke with fever of 101 accompanied by profound dizziness, muscle weakness and muscle spasm. She reported that she was unable to even hold a glass. Symptoms persisted at the same level for 24 hours then gradually diminished over the next 24 hours. She continued to complain of mild muscle weakness at 96 hours post vaccination but was able to return to work. She spoke with her PCP by phone but was not seen in the office.
Patient 10 min into monitoring, started wanted to lay down.  Pt. lowered to floor by nursing.  Slightly diaphoretic.  1st dose Pfizer 03/29/2021, 2nd dose Pfizer 04/19/2021, Booster Moderna 12/04/2021.  Vital signs @ 1050: BP 92/62, OxSat 92/62.  Vital Signs @ 1055: BP 100/60, OxSat 96%.  Vital Signs @ 1100 BP 122/82, OxSat 95%.  Pt stated he didn't drink or eat  prior to vaccination.  After giving him water and snack  pt. felt better. Symptoms were resolved.
Redness and pain at injection site for 3 days.  Improved now. Some swelling present.Now has muscle aches, shaking, weakness, lightheadness, and intermittent fever.  Lightheadedness occurs when standing from sitting.  Frontal headaches upon waking in morning.  Tmax <100.  Has abdominal pain.  Loose stool 3 times for past two days.   No blood in stool.  No cough, sore throat, nausea, or runny nose. No HA at present   No adverse reactions to injection before.  Did have minimal swelling for 3 days after last tetanus shot in 1999.
I previously developed lasting arm pain in my left arm after first dose of Moderna 7 days after the injection that I was still experiencing at the time of my second Moderna shot. I chose to get the 2nd dose in the same arm (left) as before because I didn't want to have this pain in both arms. After the 2nd shot the arm pain disappeared (besides the normal soreness). Exactly 7 days after the 2nd shot the arm pain came back just like it was after the first dose (random dull aches, intermittent sharp pains from site of injection down to end of the deltoid muscle). 26 hours after the second dose I felt a cold tingly sensation at the base of the left side of my head that lasted for a few minutes. About 5 minutes after that stopped I started to feel intermittent pain near my jaw on the left side of my face. This lasted for about an hour and then I decided to take ibuprofen. The pain in my jaw went away and never came back. 3 days after receiving my 2nd dose, I started to get cramping and severe breast tenderness. My period came 7 days later which was 1 week earlier than it should have come. During this time I noticed a large lump and a small lump in my right breast near/under the nipple. On day 5 of my period the breast tenderness has subsided, but the lumps still remain with slight tenderness to touch. I had my gynocologist exam me on Sept 1st when this started, and then went to my PCP Sept 13th to be checked again for the breast lumps. My doctor ordered me to have a mammogram to have it checked out so I have an appointment scheduled for today.
Information has been received from a respiratory therapist concerning a 11 year old female patient with no pertinent medical history and no known drug allergies, who on 26-JAN-2009 was vaccinated with the first dose of GARDASIL (lot# 661703/0651X) 0.5 ml intramuscularly. Concomitant therapy included CLARITIN. On 26-JAN-2009, four minutes after receiving the injection, the patient experienced pain, swelling and redness at the injection site, and the area was hot to the touch. The patient applied ice to the area. Additional information has been requested.
10/2: Vet phones in to report what he suspects to be an adverse reaction to his flu  vaccine received on 22 Sep 08; he describes the immediate surrounding area to be  slightly reddened, tender and raised also experiencing mild soreness in left  deltoid.  Denies resp. problems, denies n/v/d or headache, afebrility noted; PCP  made aware, MD to eval.
developed shingles a couple of days later; This case was reported by a other health professional and described the occurrence of shingles in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, several days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The age group was not reported but was captured as adult as per the vaccine indication. The age at vaccination was not reported. Couple of days after receiving Shingrix, the patient developed shingles.
Patient has a 1st dose of the Johnson and Johnson on 24Apr2022 and 3 doses of the Pfizer covid vaccine.; This is a spontaneous report received from a contactable reporter(s) (Nurse), Program ID:   A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2 (initial Pfizer dose), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Johnson & Johnson (Dose 1), administration date: 24Apr2022, for COVID-19 Immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown", described as "Patient has a 1st dose of the Johnson and Johnson on 24Apr2022 and 3 doses of the Pfizer COVID vaccine.". Additional information: The patient stated that she was not sure if the J and J vaccine was a booster dose or just the 1st dose. The patient also received dose 3 (booster), single and dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
arm soreness, body aches, abdominal pain, nausea/vomiting, fatigue
got COVID with minimal symptoms; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (got COVID with minimal symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   In June 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jul-2022, the patient experienced COVID-19 (got COVID with minimal symptoms). At the time of the report, COVID-19 (got COVID with minimal symptoms) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2022, SARS-CoV-2 test: (Negative) tested negative on the 23 or 24. No concomitant medication was provided by the reporter. It was reported that patient was senior and got COVID around 13-Jul-2022 with minimal symptoms. Patient tested negative on the 23rd or 24th. Patient had to wait 3 months to get the newest vaccine. Patient had had two regular shots and then the two boosters. No treatment medication was provided by the reporter. Reporter did not allow further contact
30 minutes post vax, the pt began with violent shaking, cold feeling, and intense headache.
LEFT ARM SWOLLEN-DELAYED REACTION. Began two days after injection. Received mutiple injections this day.
Fussy, unconsolable crying > 3 hours,pale spell 24 hrs + 48 hrs after.
04/06/23 I woke up with a sore throat, headache that would not go away, nauseous, and very fatigued. This lasted for a week and my symptoms progressed. I had a fever that would not go away. The headache was non stop. I lost my sense of taste and smells. I had body aches, chills, cough that would not stop and very congested. I tested negative for COVID with an at home COVID test. I took Mucinex and cough drops for a week. I went to the doctor on 4/13/23 and tested negative for COVID. On 4/17/23 the doctor asked me to take another at home COVID test which was positive. I was prescribed Azithromycin, Benzonatate, Prednisone and Ondansetron. I did not feel better until 5/6/23.
She said that she did ok with the first 2 doses and only felt sick for a couple of days afterward.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 32 year-old female patient received bnt162b2 (BNT162B2), administration date 24Apr2021 (Lot number: ER8727) at the age of 32 years as dose 1, single and administration date 15May2021 (Lot number: EW0168) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: ILLNESS (non-serious) with onset 2021, outcome "recovered" (2021), described as "She said that she did ok with the first 2 doses and only felt sick for a couple of days afterward.".  Additional information: Prior Vaccinations patient did not had any other vaccinations within four weeks prior to the first administration date of the suspect vaccine.  Follow-up attempts are completed. No further information is expected.
DIED; REACTION NOS; This spontaneous report received from a consumer via a company representative via social media  concerned multiple patients of unknown age, sex, race and ethnicity.  No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported, 1 total (dose number in series: 1) administered for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the patient died from unknown cause of death and reaction nos. The reporter stated that "others who did have a reaction to and died" . "You may have later in life from the vaccine it's your choice to get it .Don't criticize others who didn't .We have neighbors who were healthy get it and died the next day after receiving the vaccine". It was unknown if an autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: V0: 20211225095 -COVID-19 VACCINE AD26.COV2.S- Died This event(s) is considered unassessable .The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Grandmother called 10/24/02 stating "my granddaughter had the chickenpox shot two weeks ago and now she has red, blister-like sores all over her." Nurse spoke with client who stated she felt like she had the flu on 10/22/02; fever; tired; achy and had a bump on her scalp." Stated she "feels fine now on afternoon" of 10/24/02. Nurse stated, "your granddaughter may have been exposed to the chickenpox virus prior to receiving the vaccine." Grandmother stated "none of her friends have it." Nurse explained occasionally in some receipients of the vaccine, the vaccine is not 100% effective in preventing the disease. Nurse will follow up. 10/24/02 1:15pm, nurse returned call to client's home, and spoke with client who stated "grandmother called the doctor's office and they said I had chickenpox and told us what to do." Asked how she was feeling and client stated "I feel better this afternoon but on Tuesday 10/22/02 I felt I had a fever ; was tired and achy, and had a bump on my scalp."
After patient received the vaccination, within moments she fainted and fell to the floor from a seated position, pharmacists immediately responded and patient regained consciousness almost immediately. Patient reports hitting her head and a sore neck. patient was monitored by pharmacist until patient was back to baseline. Upon leaving patient states feeling fine and refused additional medical treatment at the time of leaving.
COVID-19 Vaccine EUA Patient received first dose of COVID-19 vaccine on May 7, 2021.  Within a couple minutes of receiving the vaccine, patient developed a headache.  Headache subsided for an hour.  Headache returned and remains as a dull headache continually since the injection.  Injection site began itching within one hour of administration. Injection site itched off and on for about 48 hours while awake, while sleeping, in the shower, etc. Itching has resolved. Upon waking the morning after receiving the 1st dose of the Moderna vaccine, patient's Index finger on left hand (same arm as injection) was swollen mostly below the knuckle toward the wrist (not the fingertip).  Swelling has subsided considerably but there is still slight swelling in the finger as of today, 11-May-2021.  There was some soreness at the injection site and the arm was warm to the touch for 3 days following the injection.
The patient self reported a mainly full-torso rash that was blistering, as well as injection site swelling that occurred along with the reaction. She mentioned the arm at injection site did not swell until after 2 weeks post vaccine administration.
Patient reports that 12 hours after the vaccine was administered, she woke up in the night freezing cold and "convulsing".  She got out of bed, took some Tylenol, and went back to bed and it resolved.
Turned into a bruise; Injection site SWelling; It's hard; It became itchy; Redness around the site/baseball size redness; Ear became very hot; Redness of external ear; Site become very hot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Ear became very hot), CONTUSION (Turned into a bruise), ERYTHEMA (Redness of external ear), VACCINATION SITE WARMTH (Site become very hot) and VACCINATION SITE PRURITUS (It became itchy) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021 at 1:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING HOT (Ear became very hot) and VACCINATION SITE WARMTH (Site become very hot). 22-Jan-2021, the patient experienced ERYTHEMA (Redness of external ear). On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness around the site/baseball size redness). On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (It became itchy). On 29-Jan-2021, the patient experienced VACCINATION SITE INDURATION (It's hard). On an unknown date, the patient experienced CONTUSION (Turned into a bruise) and VACCINATION SITE SWELLING (Injection site SWelling). At the time of the report, FEELING HOT (Ear became very hot), CONTUSION (Turned into a bruise), ERYTHEMA (Redness of external ear), VACCINATION SITE WARMTH (Site become very hot), VACCINATION SITE PRURITUS (It became itchy), VACCINATION SITE INDURATION (It's hard) and VACCINATION SITE SWELLING (Injection site SWelling) outcome was unknown and VACCINATION SITE ERYTHEMA (Redness around the site/baseball size redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: No new information
Swelling of lymph nodes in armpit of arm where injection was administered.; This is a spontaneous report from a contactable Consumer.   A 43-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3247, expiration date unknown), via an unspecified route of administration, administered in Right arm on 24-FEB-2021 11:45 (at the age of 43 old) as single dose for COVID-19 immunisation. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3247, expiration date unknown), via an unspecified route of administration, administered in Right arm on 03Feb2021 11:00 AM for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included ethinylestradiol, norgestrel (CRYSELLE), colecalciferol (D3), fish oil and centrum multivitamin (patient medications in two weeks). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Feb2021, the patient had experienced swelling of lymph nodes in armpit of arm where injection was administered. The patient not received treatment for the event. The adverse event did not resulted in emergency room. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of this report event outcome was not recovered.
High fever of 101 and above. Contracted chicken pox from the varicella vaccine which lasted one week. Stopped eating solid foods for over two weeks. Extreme thirst. Leg spasems. Abnormal behavior including laying on the floor staring into space or whining refusing to get up or move and being uninterested in playing. Extremely lethargic. He will suddenly start scratching of hitting his head he will scratch until his head and neck bleed. Took to the doctor who stated it was only eczema even though there was no signs of it present but because I (the mother) have it that is all it most likely was. Doctor ignored other symptoms and refused to consider that this could be vaccine related. I have since gotten a second opinion of a pediatric nurse who stated that it was a adverse reaction to the vaccine and to contact VAERS immediately.
I started getting a rash all over my body - little red itchy bumps that itch like crazy. So far has only grown worse. Treating with Benadryl and hydrocortisone cream.
This spontaneous report was received from a registered nurse, referring to multiple unspecified patients. The patients' medical history, concomitant medications, concurrent conditions, drug and allergy history were not provided. It was reported that on unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II, lot number M036544, expiration date 15-AUG-2018 or lot number M016234, expiration date 31-MAR-2018 (dose and administration route were not reported) for prophylaxis. Temperatures and time frames registered in the data logger, were: 0°Centigrades (C) to 1°C (0.8°C) for 34 hours; 9°C to 25°C (8.7°C) for 27 hours and 26°C or warmer (26.2°C) for 27 hours. No adverse effects were reported. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1707USA004510: US-009507513-1707USA005548: US-009507513-1707USA005549: US-009507513-1707USA005550: US-009507513-1707USA005551.